newsfilter
← Latest News
PR Newswire·

MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth

TORONTO, Aug. 14, 2023 /CNW/ - MediPharm Labs Corp. (TSX:LABS) (OTCQB:MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based